| MeSH term | MeSH ID | Detail |
|---|---|---|
| Brain Infarction | D020520 | 17 associated lipids |
| Hirsutism | D006628 | 3 associated lipids |
| Polycystic Ovary Syndrome | D011085 | 14 associated lipids |
| Hypocalcemia | D006996 | 12 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Endocrine System Diseases | D004700 | 4 associated lipids |
| Nerve Degeneration | D009410 | 53 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Periodontitis | D010518 | 22 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Hsu BG et al. | Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study. | 2016 | Medicine (Baltimore) | pmid:27082570 |
| Darabi H et al. | Adiponectin as a Protective Factor Against the Progression Toward Type 2 Diabetes Mellitus in Postmenopausal Women. | 2015 | Medicine (Baltimore) | pmid:26287420 |
| Watanabe Y et al. | IL-1beta suppresses the formation of osteoclasts by increasing OPG production via an autocrine mechanism involving celecoxib-related prostaglandins in chondrocytes. | 2009 | Mediators Inflamm. | pmid:20204061 |
| Bartosińska J et al. | The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. | 2015 | Mediators Inflamm. | pmid:26146462 |
| Sfiridaki K et al. | Angiogenesis-related cytokines, RANKL, and osteoprotegerin in multiple myeloma patients in relation to clinical features and response to treatment. | 2011 | Mediators Inflamm. | pmid:21941412 |
| Takai S et al. | (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK. | 2008 | Mediators Inflamm. | pmid:19148296 |
| Lenglet S et al. | Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis. | 2014 | Mediators Inflamm. | pmid:24648660 |
| D'Abramo A et al. | Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. | 2014 | Mediators Inflamm. | pmid:25374442 |
| Tisato V et al. | GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients. | 2013 | Mediators Inflamm. | pmid:24327798 |
| Nogueira AV et al. | Biomechanical loading modulates proinflammatory and bone resorptive mediators in bacterial-stimulated PDL cells. | 2014 | Mediators Inflamm. | pmid:24976684 |
| Toffoli B et al. | Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. | 2016 | Mediators Inflamm. | pmid:28070143 |
| Klimek E et al. | Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. | 2014 | Mediators Inflamm. | pmid:24864133 |
| Milanova V et al. | TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice. | 2014 | Mediators Inflamm. | pmid:24757287 |
| Wei CC et al. | Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis. | 2016 | Mediators Inflamm. | pmid:27199510 |
| Song DH et al. | Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis. | 2016 | Med. Sci. Monit. | pmid:27068490 |
| Wang C et al. | Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. | 2016 | Med. Sci. Monit. | pmid:26939934 |
| Sypniewska G et al. | Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status? | 2010 | Med. Sci. Monit. | pmid:20110921 |
| Zhou J and Zhao Y | Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population. | 2016 | Med. Sci. Monit. | pmid:27828936 |
| Giaginis C et al. | Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis. | 2012 | Med. Sci. Monit. | pmid:23018352 |
| Andelković Z et al. | [Osteoprotegerin--a neutralizing receptor, protector of bones and a potential antiresorptive agent]. | 2005 Jul-Aug | Med. Pregl. | pmid:16296579 |
| Lou Z et al. | Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone. | 2013 | Med. Oncol. | pmid:23690270 |
| Hjertner Ø et al. | Bone disease in multiple myeloma. | 2006 | Med. Oncol. | pmid:17303901 |
| Inanc M et al. | Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid. | 2014 | Med. Oncol. | pmid:24448976 |
| Zhang F et al. | Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women. | 2013 | Med. Oncol. | pmid:23335067 |
| Nawroth P et al. | [Osteoporosis and cardiovascular disease--two sides of the same coin?]. | 2003 | Med. Klin. (Munich) | pmid:12928809 |
| Norazlina M et al. | Effects of vitamin E on receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in rats treated with nicotine. | 2010 | Med. J. Malaysia | pmid:21265240 |
| Qin H and Yang FS | Calcitonin may be a useful therapeutic agent for osteoclastogenesis syndromes involving premature eruption of the tooth. | 2008 | Med. Hypotheses | pmid:18023993 |
| Lu L et al. | A novel therapeutic strategy for adolescent idiopathic scoliosis based on osteoporotic concept. | 2013 | Med. Hypotheses | pmid:23562283 |
| Li Y and Tang L | Local delivery of osteoprotegerin may be a way of reinforcing orthodontic anchorage. | 2009 | Med. Hypotheses | pmid:18951727 |
| Wang J et al. | Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system. | 2013 | Med. Hypotheses | pmid:24074896 |
| Ambroszkiewicz J et al. | [Biochemical bone resorption markers in children with osteosarcoma]. | 2004 Apr-Jun | Med Wieku Rozwoj | pmid:15738598 |
| Ambroszkiewicz J et al. | [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. | 2012 Apr-Jun | Med Wieku Rozwoj | pmid:22971655 |
| Scott JP et al. | Effect of recovery duration between two bouts of running on bone metabolism. | 2013 | Med Sci Sports Exerc | pmid:23034642 |
| GarcÃa-MartÃn A et al. | [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]. | 2012 | Med Clin (Barc) | pmid:22024564 |
| Vaccarezza M et al. | Increased OPG expression and impaired OPG/TRAIL ratio in the aorta of diabetic rats. | 2007 | Med Chem | pmid:17627577 |
| Shiba H et al. | Effects of ageing on proliferative ability, and the expressions of secreted protein, acidic and rich in cysteine (SPARC) and osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human periodontal ligament cells. | 2000 | Mech. Ageing Dev. | pmid:10958924 |
| Peris P et al. | Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. | 2013 | Mayo Clin. Proc. | pmid:23228561 |
| Choi HJ et al. | Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss. | 2008 | Maturitas | pmid:18572334 |
| Rojano-MejÃa D et al. | TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. | 2012 | Maturitas | pmid:22079369 |
| Vidal C et al. | TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta. | 2006 | Maturitas | pmid:16343827 |
| Albu A et al. | Bone metabolism regulators and arterial stiffness in postmenopausal women. | 2013 | Maturitas | pmid:23916080 |
| Pennisi P et al. | The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role? | 2010 | Maturitas | pmid:20727694 |
| Markatseli AE et al. | Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women. | 2011 | Maturitas | pmid:21840657 |
| Gallagher JC | Advances in bone biology and new treatments for bone loss. | 2008 | Maturitas | pmid:18555623 |
| Mencej-BedraÄ S et al. | TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women. | 2011 | Maturitas | pmid:21411255 |
| Messalli EM et al. | Raloxifene therapy interacts with serum osteoprotegerin in postmenopausal women. | 2007 | Maturitas | pmid:16787719 |
| Piatek S et al. | Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis. | 2013 | Maturitas | pmid:23391500 |
| Mlakar SJ et al. | Testing GSTP1 genotypes and haplotypes interactions in Slovenian post-/pre-menopausal women: novel involvement of glutathione S-transferases in bone remodeling process. | 2012 | Maturitas | pmid:22221655 |
| Arko B et al. | Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. | 2005 | Maturitas | pmid:15978970 |
| Kose O et al. | Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. | 2016 | Mar Drugs | pmid:27043583 |
| Park YJ et al. | Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1. | 2014 | Lupus | pmid:24531425 |
| Kwok SK et al. | Circulating osteoprotegerin levels are elevated and correlated with antiphospholipid antibodies in patients with systemic lupus erythematosus. | 2009 | Lupus | pmid:19151114 |
| Castellino G et al. | Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies. | 2007 | Lupus | pmid:17670845 |
| Monegal A et al. | Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease. | 2007 | Liver Int. | pmid:17403189 |
| Fábrega E et al. | Osteoprotegerin and RANKL in alcoholic liver cirrhosis. | 2005 | Liver Int. | pmid:15780054 |
| Gluba-Brzózka A et al. | Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. | 2016 | Lipids Health Dis | pmid:26843213 |
| Deng L et al. | Tissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration. | 2014 | Lipids Health Dis | pmid:24712339 |
| Ma Y and Ye S | [The expression of receptor activator nuclear factor-kappaB ligand and osteoprotegerin in cholesteatoma]. | 2008 | Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | pmid:18589796 |
| Xia M et al. | [Expression and significance of nuclear factor-kappa B ligand and correlation factor in the tissue of otitis media with cholesteatoma]. | 2007 | Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | pmid:17580719 |
| Tanaka H et al. | Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts. | 2006 | Life Sci. | pmid:16266722 |
| Tanabe N et al. | IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts. | 2005 | Life Sci. | pmid:15921993 |
| Alonso V et al. | Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells. | 2009 | Life Sci. | pmid:19632246 |
| Breitkreutz I et al. | Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma. | 2008 | Leukemia | pmid:18596740 |
| Johnson DC et al. | Genetic factors influencing the risk of multiple myeloma bone disease. | 2016 | Leukemia | pmid:26669972 |
| Terpos E et al. | The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio. | 2005 | Leukemia | pmid:16079895 |
| Corso A et al. | Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls. | 2004 | Leukemia | pmid:15241438 |
| Terpos E et al. | Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma. | 2004 | Leukemia | pmid:15215875 |
| Locklin RM et al. | Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment. | 2007 | Leukemia | pmid:17315027 |
| Rabin N et al. | A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer. | 2007 | Leukemia | pmid:17657224 |
| Li Q et al. | 17beta-Estradiol overcomes human myeloma RPMI8226 cell suppression of growth, ALP activity, and mineralization in rat osteoblasts and improves RANKL/OPG balance in vitro. | 2009 | Leuk. Res. | pmid:19167063 |
| Barillé-Nion S and Bataille R | New insights in myeloma-induced osteolysis. | 2003 | Leuk. Lymphoma | pmid:14565645 |
| Roux S and Mariette X | The high rate of bone resorption in multiple myeloma is due to RANK (receptor activator of nuclear factor-kappaB) and RANK Ligand expression. | 2004 | Leuk. Lymphoma | pmid:15359989 |
| Kim YD et al. | Effect of low-level laser treatment after installation of dental titanium implant-immunohistochemical study of RANKL, RANK, OPG: an experimental study in rats. | 2007 | Lasers Surg Med | pmid:17523169 |
| Aihara N et al. | Low-energy irradiation stimulates formation of osteoclast-like cells via RANK expression in vitro. | 2006 | Lasers Med Sci | pmid:16568210 |
| Kwon H et al. | Effect of 635 nm irradiation on high glucose-boosted inflammatory responses in LPS-induced MC3T3-E1 cells. | 2013 | Lasers Med Sci | pmid:22699799 |
| Kim YD et al. | Expression of receptor activator of nuclear factor -kappaB ligand, receptor activator of nuclear factor -kappaB, and osteoprotegerin, following low-level laser treatment on deproteinized bovine bone graft in rats. | 2009 | Lasers Med Sci | pmid:18825474 |
| Altan BA et al. | Metrical and histological investigation of the effects of low-level laser therapy on orthodontic tooth movement. | 2012 | Lasers Med Sci | pmid:21038101 |
| CalderÃn S et al. | Short-term clinical and osteoimmunological effects of scaling and root planing complemented by simple or repeated laser phototherapy in chronic periodontitis. | 2013 | Lasers Med Sci | pmid:22546942 |
| Karosi T et al. | Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic Stapes footplates in connection with measles virus positivity. | 2006 | Laryngoscope | pmid:16885748 |
| Zehnder AF et al. | Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss. | 2006 | Laryngoscope | pmid:16467704 |
| Jeong JH et al. | Expression of RANKL and OPG in middle ear cholesteatoma tissue. | 2006 | Laryngoscope | pmid:16826057 |
| Zehnder AF et al. | Osteoprotegerin in the inner ear may inhibit bone remodeling in the otic capsule. | 2005 | Laryngoscope | pmid:15630389 |
| Hamzei M et al. | Osteoclast stimulating and differentiating factors in human cholesteatoma. | 2003 | Laryngoscope | pmid:12616193 |
| Sudhoff H et al. | [Expression of osteoclast stimulating and differentiating factors in a murine model of localized inflammatory bone resorption]. | 2004 | Laryngorhinootologie | pmid:14740300 |
| Burton A | Regulation of RANKL might reduce bone metastases . | 2006 | Lancet Oncol. | pmid:16696160 |
| Richards JB et al. | Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. | 2008 | Lancet | pmid:18455228 |
| Kannus P et al. | Fractures are not in genes. | 2008 | Lancet | pmid:18970970 |
| Tricot G | New insights into role of microenvironment in multiple myeloma. | 2000 | Lancet | pmid:10675068 |
| Hofbauer LC and Schoppet M | Osteoprotegerin: a link between osteoporosis and arterial calcification? | 2001 | Lancet | pmid:11498208 |
| Chakravarti A et al. | Normal human primary CD4+ T lymphocytes synthesize and release functional osteoprotegerin in vitro. | 2008 | Lab. Invest. | pmid:18040268 |
| Teramachi J et al. | Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis. | 2011 | Lab. Invest. | pmid:21339747 |
| Taylor RM et al. | CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst. | 2012 | Lab. Invest. | pmid:22330339 |
| Cody JJ et al. | Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model. | 2013 | Lab. Invest. | pmid:23358109 |
| Yamano E et al. | Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis. | 2010 | Lab. Invest. | pmid:20421871 |
| Ko GJ | A biomarker, osteoprotegerin, in patients undergoing hemodialysis. | 2013 | Korean J. Intern. Med. | pmid:24307839 |
| Lee JE et al. | Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients. | 2013 | Korean J. Intern. Med. | pmid:24307842 |
| Confavreux CB | Bone: from a reservoir of minerals to a regulator of energy metabolism. | 2011 | Kidney Int. Suppl. | pmid:21346725 |
| Ohkido I et al. | The hypothesis that bone turnover influences FGF23 secretion. | 2010 | Kidney Int. | pmid:20354552 |
| Sanchez-Niño MD et al. | New paradigms in cell death in human diabetic nephropathy. | 2010 | Kidney Int. | pmid:20703212 |
| Barreto FC et al. | Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem. | 2006 | Kidney Int. | pmid:16612334 |